Multi-glycoside of Tripterygium wilfordii Hook f. ameliorates prolonged mesangial lesions in experimental progressive glomerulonephritis

Nephron - Experimental Nephrology

Volumn 114, Issue 1, 2010, Pages

  Wan, Yigang ^a,b   Sun, Wei ^c   Zhang, Huilan ^d   Yan, Qiaojing ^d   Chen, Ping ^d   Dou, Chenhui ^d   Yang, Haiming ^a   Ge, Ming ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^c AFFILIATED HOSPITAL OF NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^d NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Cytokines; Glomerulosclerosis; Mesangial lesions; Multi glycoside of Tripterygium wilfordii Hook f.; Progressive glomerulonephritis

Indexed keywords

CREATININE; GAMMA INTERFERON; INTERLEUKIN 2; MESSENGER RNA; MONOCLONAL ANTIBODY; PLANT GLYCOSIDE; TRANSFORMING GROWTH FACTOR BETA; TRIPTERYGIUM WILFORDII EXTRACT; TRYPTERYGIUM WILFORDII MULTIGLYCOSIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOKINE PRODUCTION; DISEASE COURSE; DRUG EFFECT; DRUG MECHANISM; FEMALE; GLOMERULONEPHRITIS; INFLAMMATORY CELL; KIDNEY FUNCTION; MACROPHAGE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; PROTEINURIA; RAT; T LYMPHOCYTE; UREA NITROGEN BLOOD LEVEL;

ANIMALS; DISEASE MODELS, ANIMAL; GLOMERULONEPHRITIS; GLYCOSIDES; HUMANS; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, WISTAR; TREATMENT OUTCOME; TRIPTERYGIUM;

EID: 70349827132     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000245061     Document Type: Article

References (26)

1. Shimizu F, Kawachi H, Orikasa M: Role of mesangial cell damage in progressive renal disease. Kidney Blood Press Res 1999; 22: 5-12.
2. Jefferson JA, Johnson RJ: Experimental mesangial proliferative glomerulonephritis (the anti-Thy-1.1 model). J Nephrol 1999; 12: 297-307.
3. Remuzzi G, Bertani T: Pathophysiology of progressive nephropathies. N Engl J Med 1998; 339:1448-1456.
4. Strippoli GF, Manno C, Schena FP: An 'evidence-based' survey of therapeutic options for IgA nephropathy: assessment and criticism. Am J Kidney Dis 2003; 41:1129-1139.
5. Qian SZ, Xu Y, Zhang JW: Recent progress in research on Tripterygium: a male antifertility plant. Contraception 1995; 51: 121-129.
6. Rong S, Hu WX, Liu ZH, Tang Z, Li LS: A new regime of Tripterygium wilfordii Hook f. in treating primary mesangial proliferative glomerulonephritis (in Chinese). J Nephrol Dial Transplant 1998; 7:409-414.
7. Wan Y, Gu L, Suzuki K, Karasawa T, Fujioka Y, Han GD, Koike H, Kawachi H, Shimizu F: Multi-glycoside of Tripterygium wilfordii Hook f. ameliorates proteinuria and acute mesangial injury induced by anti-Thy-1.1 monoclonal antibody. Nephron Exp Nephrol 2005; 99:e121-e129.
8. Kawachi H, Iwanaga T, Toyabe S, Oite T, Shimizu F: Mesangial sclerotic change with persistent proteinuria in rats after two consecutive injections of monoclonal antibody 1-22-3. Clin Exp Immunol 1992; 90: 129-134.
9. Raij L, Azar S, Keane W: Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int 1984; 26:137-143.
10. Floege J, Johnson RJ, Gordon K, Iida H, Pritzl P, Yoshimura A, Campbell C, Alpers CE, Couser WG: Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int 1991; 40: 477-488.
11. Krakower CA, Greenspon SA: Direct evidence for antigenicity of the glomeruli in the production of nephrotoxic serums. Arch Pathol 1951; 51: 629-639.
12. Tsuji T, Okada F, Yamaguchi K, Nakamura T: Molecular cloning of the large subunit of transforming growth factor type β masking protein and expression of the mRNA in various rat tissues. Proc Natl Acad Sci USA 1990; 87: 8835-8839.
13. Chu ML, Meyers JC, Bernard MP, Ding JF, Ramirez F: Cloning and characterization of five overlapping cDNA specific for the human pro α1(I) collagen chain. Nucleic Acids Res 1982; 10:5925-5934.
14. Siegling A, Lehmann M, Platzer C, Emmrich F, Volk HD: A novel multispecific competitor fragment quantitative PCR analysis of cytokine gene expression in rats. J Immunol Methods 1994; 177:23-28.
15. Wan YG, Gu LB, Shimizu F: Mechanism of protective effects of effective components in Tripterygium wilfordii Hook f. on glomerulonephritis (in Japanese). J Clin Exp Med 2003; 207:285-288.
16. Ma J, Dey M, Yang H, Poulev A, Poulev R, Dorn R, Lipsky PE, Kennelly EJ, Raskin I: Anti-inflammatory and immunosuppressive compounds from Tripterygium wilfordii. Phytochemistry 2007; 68:1172-1178.
17. Brinker AM, Ma J, Lipsky PE, Raskin I: Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae). Phy tochemistry 2007; 68:732-766.
18. Sun X, Zhang SM, Tiao CH, Yang L, Wang LM, Li SL: Safety of Tripterygium wilfordii (in Chinese). Chin J New Drugs 2001; 10: 539-543.
19. Wang C, Guo Y: The active constituents of Tripterygium wilfordii and their pharmacological actions and clinical application. Chin J Integr Med 1995; 1:235-239.
20. Li LS: Clinical study of Tripterygiumwilfordii Hook in treating glomerulonephritis (in Chinese). Chin J Intern Med 1981; 20:216-220.
21. Johnson RJ: Role of cytokines and growth factor in glomerulonephritis: a chance for future therapeutic intervention. Nephron 1996; 73: 506-514.
22. Ikezumi Y, Kanno K, Karasawa T, Han GD, Ito Y, Koike H, Toyabe S, Uchiyama M, Shimizu F, Kawachi H: The role of lymphocytes in the experimental progressive glomerulonephritis. Kidney Int 2004; 66:1036-1048.
23. Isaka Y, Fujiwara Y, Ueda N, Kaneda Y, Kamada T, Imai E: Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet-derived growth factor gene into the rat kidney. J Clin Invest 1993; 92: 2597-2601.
24. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti E: Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 1992; 360: 361-364.
25. Ikezumi Y, Hurst LA, Masaki T, Atkins RC, Nikolic-Paterson DJ: Adoptive transfer studies demonstrate that macrophages can induce proteinuria and mesangial cell proliferation. Kidney Int 2003; 63:83-95.
26. Kobayashi H, Orikasa M, Naito M, Kawasaki K, Oite T, Kawachi H, Yamashita A, Takeya M, Nihei H, Shimizu F: Detailed analysis of phenotypes of macrophages infiltrating glomeruli in rat anti-Thy-1 nephritis. Nephron 1997; 77: 333-339.